Chemours Files Second Lawsuit Against AGC, Inc. for Infringement of HFO-1234yf Patent
PR93189
WILMINGTON, Del., On, Nov. 19, 2021 /PRNewswire=KYODO JBN/--
- Stopping the unlicensed manufacture, marketing, and sales of HFO-1234yf
refrigerants protects innovation and customers
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with
leading market positions in Titanium Technologies, Thermal & Specialized
Solutions, Advanced Performance Materials and Chemical Solutions, announced
that it files a second patent infringement lawsuit in Japan against AGC, Inc.
This action reaffirms Chemours' commitment to vigorously defend its
intellectual property and investment in Opteon(TM) low global warming potential
(GWP) refrigerants and builds on its on-going efforts to stop the unlicensed
manufacture, marketing, and sales of Opteon(TM) HFO-1234yf (R-1234yf)
refrigerant by all legal means wherever that activity occurs around the world.
The second lawsuit was filed on November 12, 2021 with the Tokyo District Court
Civil Divisio (case number 2021(Wa)29388). It alleges infringement of Chemours'
patents covering HFO-1234yf product compositions. This is a great example of
Chemours' using its international patent estate in order to protect its
investment in the development and commercialization of HFO-1234yf and to ensure
that customers obtain authentic refrigerant.
Chemours offers a full portfolio of low GWP HFO solutions under the Opteon(TM)
brand that delivers the optimal balance of performance, safety, sustainability
and total cost of ownership to meet the long-term needs of the commercial
refrigeration, air conditioning, heat pump, and chiller markets. They have been
developed to help meet increasingly stringent global regulations while
maintaining or improving performance compared to the products they replace, as
well as encouraging more sustainable refrigerant choices and equipment designs
to reduce the carbon footprint of the HVACR industry.
For more information on Opteon(TM) refrigerants, please visit opteon.com
About The Chemours Company
The Chemours Company (Chemours or the Company) (NYSE: CC) is a global leader in
Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance
Materials, and Chemical Solutions providing its customers with solutions in a
wide range of industries with market-defining products, application expertise
and chemistry-based innovations. We deliver customized solutions with a wide
range of industrial and specialty chemicals products for markets, including
coatings, plastics, refrigeration, and air conditioning, transportation,
semiconductor and consumer electronics, general industrial, mining and oil and
gas. Our flagship products include prominent brands such as Ti-Pure(TM),
Opteon(TM), Freon(TM), Nafion(TM), Krytox(TM), Teflon(TM), and Viton(TM). In
2019, Chemours was named to Newsweek's list of America's Most Responsible
Companies. The company has approximately 6,500 employees and 30 manufacturing
sites serving approximately 3,300 customers in approximately 120 countries.
Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE
under the symbol CC.
For more information, we invite you to visit chemours.com or follow us on
Twitter @Chemours or LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, which involve risks and uncertainties. Forward-looking
statements provide current expectations of future events based on certain
assumptions and include any statement that does not directly relate to a
historical or current fact. The words "believe," "expect," "will,"
"anticipate," "plan," "estimate," "target," "project" and similar expressions,
among others, generally identify "forward-looking statements," which speak only
as of the date such statements were made. These forward-looking statements may
address, among other things, the outcome or resolution of any pending or future
environmental liabilities, the commencement, outcome or resolution of any
regulatory inquiry, investigation or proceeding, the initiation, outcome or
settlement of any litigation, changes in environmental regulations in the U.S.
or other jurisdictions that affect demand for or adoption of our products,
anticipated future operating and financial performance for our segments
individually and our company as a whole, business plans, prospects, targets,
goals and commitments, capital investments and projects and target capital
expenditures, plans for dividends or share repurchases, sufficiency or
longevity of intellectual property protection, cost reductions or savings
targets, plans to increase profitability and growth, our ability to make
acquisitions, integrate acquired businesses or assets into our operations, and
achieve anticipated synergies or cost savings, all of which are subject to
substantial risks and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statements. Forward-looking
statements are based on certain assumptions and expectations of future events
that may not be accurate or realized. These statements are not guarantees of
future performance. Forward-looking statements also involve risks and
uncertainties that are beyond Chemours' control. In addition, the current
COVID-19 pandemic has significantly impacted the national and global economy
and commodity and financial markets, which has had and we expect will continue
to have a negative impact on our financial results. The full extent and impact
of the pandemic is unknown and to date has included extreme volatility in
financial and commodity markets, a significant slowdown in economic activity,
and increased predictions of a global recession. The public and private sector
response has led to significant restrictions on travel, temporary business
closures, quarantines, stock market volatility, and a general reduction in
consumer and commercial activity globally. Matters outside our control have
affected our business and operations and may or may continue to limit travel of
employees to our business units domestically and internationally, adversely
affect the health and welfare of our personnel, significantly reduce the demand
for our products, hinder our ability to provide goods and services to
customers, cause disruptions in our supply chains, adversely affect our
business partners or cause other unpredictable events. Additionally, there may
be other risks and uncertainties that Chemours is unable to identify at this
time or that Chemours does not currently expect to have a material impact on
its business. Factors that could cause or contribute to these differences
include the risks, uncertainties and other factors discussed in our filings
with the U.S. Securities and Exchange Commission, including in our Quarterly
Report on Form 10-Q for the quarter ended September 30, 2021 and in our Annual
Report on Form 10-K for the year ended December 31, 2020. Chemours assumes no
obligation to revise or update any forward-looking statement for any reason,
except as required by law.
SOURCE: Chemours
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。